A detailed history of Mcf Advisors LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 207 shares of HROW stock, worth $7,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207
Holding current value
$7,002
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$20.85 - $46.47 $4,315 - $9,619
207 New
207 $9,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $916M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.